References
- Ansari A, Maron BJ, Berntson DG. Drug induced toxic myocarditis. Tex Heart Inst J 2003; 30: 76–79
- Antman EM, Braunwald E. ST-segment elevation myocardial infarction. Harrisons principles of internal medicine, DL Kasper, E Braunwald, AS Fauci, SL Hauser, DL Longo, JL Jameson. McGraw Hill, New York 2005; 1448–1459
- Coulter DM, Bate A, Meyboom RHB, Lindquist M, Edwards IR. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. Br Med J 2001; 322: 1207–1209
- Grenade LL, Graham D, Trontell A. Myocarditis and cardiomayopathy associated with clozapine use in United States. New Eng J Med 2001; 345: 224–225
- Kilian JG, Kerr K, Lawrance C, Celermajer DS. Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999; 354: 1841–1845
- Kirpekar VC, Deshpande SM, Joshi PP. Reversible myocarditis in a patient receiving clozapine. Indian Heart J 2001; 53: 779–781
- Norquist GS, Narrow WE. Schizophrenia: Epidemiology. Comprehensive textbook of psychiatry, BJ Sadock, VA Sadock. Lippincott Williams and Williams, Philadelphia, PA 2000; 1110–1116
- Roesch-Ely D, Einsiedel RV, Kathöfer S, Schwaninger M, Weisbrod M. Myocarditis with quetiapine. Am J Psychiatry 2002; 159: 1607–1608
- Wynne J, Braunwald E. Cardiomyopathy and myocarditis. Harrisons principles of internal medicine, DL Kasper, E Braunwald, AS Fauci, SL Hauser, DL Longo, JL Jameson. McGraw Hill, New York 2005; 1408–1414